» Articles » PMID: 33371340

Barocrinology: The Endocrinology of Obesity from Bench to Bedside

Overview
Journal Med Sci (Basel)
Specialty General Medicine
Date 2020 Dec 29
PMID 33371340
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity has reached pandemic proportions. Hormonal and metabolic imbalances are the key factors that lead to obesity. South Asian populations have a unique phenotype, peculiar dietary practices, and a high prevalence of consanguinity. Moreover, many lower middle-income countries lack appropriate resources, super-specialists, and affordability to manage this complex disorder. Of late, there has been a substantial increase in both obesity and diabesity in India. Thus, many more patients are being managed by different types of bariatric procedures today than ever before. These patients have many types of endocrine and metabolic disturbances before and after bariatric surgery. Therefore, these patients should be managed by experts who have knowledge of both bariatric surgery and endocrinology. The authors propose "Barocrinology", a novel terminology in medical literature, to comprehensively describe the field of obesity medicine highlighting the role of knowing endocrine physiology for understating its evolution, insights into its complications and appreciating the changes in the hormonal milieu following weight loss therapies including bariatric surgery. Barocrinology, coined as a portmanteau of "baro" (weight) and endocrinology, focuses upon the endocrine and metabolic domains of weight physiology and pathology. This review summarizes the key pointers of bariatric management from an endocrine perspective.

Citing Articles

Endocrine, genetic, and microbiome nexus of obesity and potential role of postbiotics: a narrative review.

Wu W, Chen Z, Han J, Qian L, Wang W, Lei J Eat Weight Disord. 2023; 28(1):84.

PMID: 37861729 PMC: 10589153. DOI: 10.1007/s40519-023-01593-w.


Subclinical Kwashiorkor in Adults: A New Age Paradigm.

Kapoor N, Bhattacharya S, Agarwal N, Das S, Bantwal G, Deshmukh V Indian J Endocrinol Metab. 2022; 26(3):213-222.

PMID: 36248046 PMC: 9555378. DOI: 10.4103/ijem.ijem_42_22.


ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity In India.

S V M, Nitin K, Sambit D, Nishant R, Sanjay K Indian J Endocrinol Metab. 2022; 26(4):295-318.

PMID: 36185955 PMC: 9519829. DOI: 10.4103/2230-8210.356236.


Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery.

Bhattacharya S, Kalra S, Kapoor N, Singla R, Dutta D, Aggarwal S World J Diabetes. 2021; 12(10):1587-1621.

PMID: 34754367 PMC: 8554368. DOI: 10.4239/wjd.v12.i10.1587.


Gender Disparities in People Living with Obesity - An Unchartered Territory.

Kapoor N, Arora S, Kalra S J Midlife Health. 2021; 12(2):103-107.

PMID: 34526743 PMC: 8409720. DOI: 10.4103/jmh.jmh_48_21.

References
1.
Steffen K, King W, White G, Subak L, Mitchell J, Courcoulas A . Sexual functioning of men and women with severe obesity before bariatric surgery. Surg Obes Relat Dis. 2016; 13(2):334-343. PMC: 6067110. DOI: 10.1016/j.soard.2016.09.022. View

2.
Wong I, Baldock P, Herzog H . Gastrointestinal peptides and bone health. Curr Opin Endocrinol Diabetes Obes. 2009; 17(1):44-50. DOI: 10.1097/MED.0b013e3283344a05. View

3.
Escobar-Morreale H, Botella-Carretero J, Alvarez-Blasco F, Sancho J, San Millan J . The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2005; 90(12):6364-9. DOI: 10.1210/jc.2005-1490. View

4.
Balen A, Morley L, Misso M, Franks S, Legro R, Wijeyaratne C . The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016; 22(6):687-708. DOI: 10.1093/humupd/dmw025. View

5.
Yu H, Li Q, Zhang M, Liu F, Pan J, Tu Y . Decreased Leptin Is Associated with Alterations in Thyroid-Stimulating Hormone Levels after Roux-en-Y Gastric Bypass Surgery in Obese Euthyroid Patients with Type 2 Diabetes. Obes Facts. 2019; 12(3):272-280. PMC: 6696777. DOI: 10.1159/000499385. View